InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by PACE GARY W, Director. Insider active across 2 companies, notably Pacira BioSciences, Inc.. Aggregated, 7 disclosures have been recorded. Total volume traded: €345k. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations7 total
01,160 shares0
Common Stock
SEC:0001209191-22-035227:0·
€68,0957,000 shares@ €9.72790.0064% mcap41.3% of flow
Common Stock
SEC:0001209191-22-016876:0·
€96,6579,807 shares@ €9.8560.0091% mcap58.7% of flow
Common Stock
SEC:0001209191-22-014267:0·
€172,73930,000 shares@ €5.758100.0% of flow
Common Stock
SEC:0001628280-21-019057·
Ideal exit: 18 Jun 2022 (T+270)
€172,73930,000 shares@ €5.7580.15% mcap50.0% of flow
Common Stock
SEC:0001628280-21-019057:0·
Ideal exit: 18 Jun 2022 (T+270)
01,485 shares0
Common Stock
SEC:0001209191-21-040097:0·
01,485 shares0
Common Stock
SEC:0001209191-21-040097·
7 of 7 declarations
About PACE GARY W
Gary W Pace is a Board Member at Pacira BioSciences, Inc. and Cardiff Oncology, Inc. He is involved in overseeing operations and development strategy for both companies. His expertise in the biopharmaceutical field is an asset to the board.
